HEADER VIRAL PROTEIN/IMMUNE SYSTEM 02-JAN-25 9LAE TITLE LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH ANTIBODIES TITLE 2 9G11 AND 3E2. COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: G; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LIGHT CHAIN OF 3E2; COMPND 7 CHAIN: L; COMPND 8 MOL_ID: 3; COMPND 9 MOLECULE: HEAVY CHAIN OF 3E2; COMPND 10 CHAIN: H; COMPND 11 MOL_ID: 4; COMPND 12 MOLECULE: LIGHT CHAIN OF 9G11; COMPND 13 CHAIN: B; COMPND 14 MOL_ID: 5; COMPND 15 MOLECULE: HEAVY CHAIN OF 9G11; COMPND 16 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 MOL_ID: 3; SOURCE 13 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 14 ORGANISM_TAXID: 10090; SOURCE 15 MOL_ID: 4; SOURCE 16 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 17 ORGANISM_TAXID: 10090; SOURCE 18 MOL_ID: 5; SOURCE 19 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 20 ORGANISM_TAXID: 10090 KEYWDS SARS-COV-2, RBD, FAB, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN- KEYWDS 2 IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR Y.JIANG,H.SUN,Q.ZHENG,S.LI REVDAT 2 19-FEB-25 9LAE 1 SOURCE REVDAT 1 12-FEB-25 9LAE 0 JRNL AUTH W.JIANG,Y.JIANG,H.SUN,T.DENG,K.YU,Q.FANG,H.GE,M.LAN,Y.LIN, JRNL AUTH 2 Z.FANG,Y.ZHANG,L.ZHOU,T.LI,H.YU,Q.ZHENG,S.LI,N.XIA,Y.GU JRNL TITL STRUCTURAL INSIGHT INTO BROADENING SARS-COV-2 NEUTRALIZATION JRNL TITL 2 BY AN ANTIBODY COCKTAIL HARBOURING BOTH NTD AND RBD POTENT JRNL TITL 3 ANTIBODIES. JRNL REF EMERG MICROBES INFECT V. 13 06300 2024 JRNL REFN ESSN 2222-1751 JRNL PMID 39470577 JRNL DOI 10.1038/S41467-023-39265-Z REMARK 2 REMARK 2 RESOLUTION. 3.46 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.460 REMARK 3 NUMBER OF PARTICLES : 307127 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9LAE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 08-JAN-25. REMARK 100 THE DEPOSITION ID IS D_1300050261. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 SPIKE IN COMPLEX REMARK 245 WITH ANTIBODIES 9G11 AND 3E2; REMARK 245 THE FAB OF 3E2; SARS-COV-2 REMARK 245 SPIKE; THE FAB OF 9G11 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TECNAI F30 REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 5416.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : OTHER REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, L, H, B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG G 319 REMARK 465 VAL G 320 REMARK 465 GLN G 321 REMARK 465 PRO G 322 REMARK 465 THR G 323 REMARK 465 GLU G 324 REMARK 465 SER G 325 REMARK 465 ILE G 326 REMARK 465 VAL G 327 REMARK 465 ARG G 328 REMARK 465 PHE G 329 REMARK 465 PRO G 330 REMARK 465 ASN G 331 REMARK 465 ILE G 332 REMARK 465 PRO G 527 REMARK 465 LYS G 528 REMARK 465 LYS G 529 REMARK 465 SER G 530 REMARK 465 THR G 531 REMARK 465 ASN G 532 REMARK 465 LEU G 533 REMARK 465 VAL G 534 REMARK 465 LYS G 535 REMARK 465 ASN G 536 REMARK 465 LYS G 537 REMARK 465 CYS G 538 REMARK 465 VAL G 539 REMARK 465 ASN G 540 REMARK 465 PHE G 541 REMARK 465 SER A 120 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER G 477 OD1 ASP A 99 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS G 361 CA - CB - SG ANGL. DEV. = 7.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE G 342 -60.58 -102.15 REMARK 500 ASN G 343 61.22 -100.66 REMARK 500 ALA G 372 8.74 59.00 REMARK 500 LEU G 390 119.88 178.29 REMARK 500 ASP G 427 47.84 -91.46 REMARK 500 ASP G 428 27.47 -142.99 REMARK 500 THR G 470 51.53 -92.76 REMARK 500 GLU G 484 37.86 -96.94 REMARK 500 THR L 50 -12.67 73.04 REMARK 500 TRP L 93 -9.61 73.34 REMARK 500 SER H 30 31.37 -97.06 REMARK 500 ALA H 49 145.90 -170.85 REMARK 500 ALA B 51 -3.75 68.52 REMARK 500 SER B 52 -4.77 -141.64 REMARK 500 PRO B 59 -177.06 -65.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-62925 RELATED DB: EMDB REMARK 900 LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH REMARK 900 ANTIBODIES 9G11 AND 3E2. DBREF 9LAE G 319 541 UNP P0DTC2 SPIKE_SARS2 319 541 DBREF 9LAE L 1 104 PDB 9LAE 9LAE 1 104 DBREF 9LAE H 1 121 PDB 9LAE 9LAE 1 121 DBREF 9LAE B 1 107 PDB 9LAE 9LAE 1 107 DBREF 9LAE A 1 120 PDB 9LAE 9LAE 1 120 SEQRES 1 G 223 ARG VAL GLN PRO THR GLU SER ILE VAL ARG PHE PRO ASN SEQRES 2 G 223 ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA SEQRES 3 G 223 THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG SEQRES 4 G 223 ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SEQRES 5 G 223 SER ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER SEQRES 6 G 223 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 7 G 223 ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN SEQRES 8 G 223 ILE ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN SEQRES 9 G 223 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 10 G 223 TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN SEQRES 11 G 223 TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU SEQRES 12 G 223 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 13 G 223 ALA GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN SEQRES 14 G 223 CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR SEQRES 15 G 223 ASN GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SEQRES 16 G 223 SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY SEQRES 17 G 223 PRO LYS LYS SER THR ASN LEU VAL LYS ASN LYS CYS VAL SEQRES 18 G 223 ASN PHE SEQRES 1 L 104 GLN ILE VAL LEU THR GLN SER PRO ALA ILE MET SER ALA SEQRES 2 L 104 SER LEU GLY GLU GLU ILE THR LEU THR CYS SER VAL SER SEQRES 3 L 104 SER SER VAL SER ASP MET HIS TRP TYR GLN GLN LYS SER SEQRES 4 L 104 GLY THR SER PRO LYS VAL PHE ILE TYR SER THR SER ASN SEQRES 5 L 104 LEU ALA SER GLY VAL PRO SER ARG PHE SER GLY SER GLY SEQRES 6 L 104 SER GLY THR PHE TYR SER LEU THR ILE SER SER VAL GLU SEQRES 7 L 104 ALA GLU ASP ALA ALA TYR TYR TYR CYS HIS GLN TRP SER SEQRES 8 L 104 SER TRP THR PHE GLY GLY GLY THR LYS LEU GLU ILE LYS SEQRES 1 H 121 GLU VAL MET LEU VAL GLU SER GLY GLY GLY VAL VAL LYS SEQRES 2 H 121 PRO GLY GLY SER LEU LYS LEU SER CYS ALA ALA SER GLY SEQRES 3 H 121 PHE SER PHE SER THR TYR ALA MET SER TRP ILE ARG GLN SEQRES 4 H 121 THR PRO GLU LYS SER LEU GLU TRP VAL ALA ALA ILE SER SEQRES 5 H 121 SER GLY GLY THR ASN THR TYR TYR PRO GLY SER VAL LYS SEQRES 6 H 121 GLY ARG PHE THR ILE SER ARG ASP LYS ALA MET ASN THR SEQRES 7 H 121 LEU TYR LEU GLN LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 H 121 ALA MET TYR TYR CYS VAL ARG HIS SER GLY ASN TYR VAL SEQRES 9 H 121 ASP SER VAL MET ASP TYR TRP GLY GLN GLY THR SER VAL SEQRES 10 H 121 THR VAL SER SER SEQRES 1 B 107 ASP ILE VAL MET THR GLN SER GLN LYS PHE MET SER THR SEQRES 2 B 107 SER VAL GLY ASP ARG VAL SER VAL THR CYS LYS ALA SER SEQRES 3 B 107 GLN ASN VAL GLY THR ASN VAL ALA TRP TYR GLN GLN LYS SEQRES 4 B 107 PRO GLY GLN PRO PRO LYS ALA LEU ILE TYR SER ALA SER SEQRES 5 B 107 TYR ARG TYR SER GLY VAL PRO ASP ARG PHE THR GLY SER SEQRES 6 B 107 GLY SER GLY THR ASP PHE THR LEU THR ILE SER ASN VAL SEQRES 7 B 107 GLN SER GLU ASP LEU ALA GLU TYR PHE CYS GLN GLN TYR SEQRES 8 B 107 ASN SER TYR PRO TRP THR PHE GLY GLY GLY THR LYS LEU SEQRES 9 B 107 GLU ILE LYS SEQRES 1 A 120 GLN VAL GLN LEU GLN GLN PRO GLY ALA GLU LEU VAL LYS SEQRES 2 A 120 PRO GLY ALA SER VAL LYS MET SER CYS LYS ALA SER GLY SEQRES 3 A 120 TYR THR PHE THR SER TYR SER MET HIS TRP VAL LYS GLN SEQRES 4 A 120 THR PRO GLY GLN GLY LEU GLU TRP ILE GLY ALA ILE TYR SEQRES 5 A 120 PRO GLY ILE GLY ASP THR SER TYR ASN GLN LYS PHE LYS SEQRES 6 A 120 GLY LYS ALA THR LEU THR ALA ASP LYS SER SER SER THR SEQRES 7 A 120 ALA TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 A 120 ALA VAL TYR TYR CYS THR ARG ASP GLY TYR PRO ASP TYR SEQRES 9 A 120 TYR ALA LEU ASP TYR TRP GLY GLN GLY THR SER VAL THR SEQRES 10 A 120 VAL SER SER HET NAG G 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 6 NAG C8 H15 N O6 HELIX 1 AA1 ASP G 364 ASN G 370 1 7 HELIX 2 AA2 THR G 385 ASP G 389 5 5 HELIX 3 AA3 ASP G 405 ILE G 410 5 6 HELIX 4 AA4 SER H 28 TYR H 32 5 5 HELIX 5 AA5 ARG H 87 THR H 91 5 5 HELIX 6 AA6 THR A 28 TYR A 32 5 5 HELIX 7 AA7 THR A 87 SER A 91 5 5 SHEET 1 AA1 5 ASN G 354 ILE G 358 0 SHEET 2 AA1 5 ASN G 394 ARG G 403 -1 O SER G 399 N ASN G 354 SHEET 3 AA1 5 PRO G 507 GLU G 516 -1 O TYR G 508 N ILE G 402 SHEET 4 AA1 5 GLY G 431 ASN G 437 -1 N CYS G 432 O LEU G 513 SHEET 5 AA1 5 THR G 376 CYS G 379 -1 N LYS G 378 O VAL G 433 SHEET 1 AA2 2 LEU G 452 ARG G 454 0 SHEET 2 AA2 2 LEU G 492 SER G 494 -1 O GLN G 493 N TYR G 453 SHEET 1 AA3 4 LEU L 4 SER L 7 0 SHEET 2 AA3 4 ILE L 19 VAL L 25 -1 O SER L 24 N THR L 5 SHEET 3 AA3 4 PHE L 69 ILE L 74 -1 O LEU L 72 N LEU L 21 SHEET 4 AA3 4 PHE L 61 SER L 66 -1 N SER L 64 O SER L 71 SHEET 1 AA4 2 ILE L 10 SER L 14 0 SHEET 2 AA4 2 LYS L 100 LYS L 104 1 O LYS L 104 N ALA L 13 SHEET 1 AA5 4 ASN L 52 LEU L 53 0 SHEET 2 AA5 4 LYS L 44 TYR L 48 -1 N TYR L 48 O ASN L 52 SHEET 3 AA5 4 HIS L 33 GLN L 37 -1 N GLN L 36 O LYS L 44 SHEET 4 AA5 4 TYR L 84 HIS L 88 -1 O TYR L 84 N GLN L 37 SHEET 1 AA6 4 MET H 3 SER H 7 0 SHEET 2 AA6 4 SER H 17 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 AA6 4 THR H 78 SER H 84 -1 O LEU H 81 N LEU H 20 SHEET 4 AA6 4 THR H 69 ASP H 73 -1 N THR H 69 O GLN H 82 SHEET 1 AA7 6 VAL H 11 VAL H 12 0 SHEET 2 AA7 6 THR H 115 VAL H 119 1 O THR H 118 N VAL H 12 SHEET 3 AA7 6 ALA H 92 HIS H 99 -1 N ALA H 92 O VAL H 117 SHEET 4 AA7 6 MET H 34 GLN H 39 -1 N SER H 35 O VAL H 97 SHEET 5 AA7 6 LEU H 45 ILE H 51 -1 O ILE H 51 N MET H 34 SHEET 6 AA7 6 THR H 58 TYR H 59 -1 O TYR H 59 N ALA H 50 SHEET 1 AA8 4 VAL H 11 VAL H 12 0 SHEET 2 AA8 4 THR H 115 VAL H 119 1 O THR H 118 N VAL H 12 SHEET 3 AA8 4 ALA H 92 HIS H 99 -1 N ALA H 92 O VAL H 117 SHEET 4 AA8 4 MET H 108 TRP H 111 -1 O TYR H 110 N ARG H 98 SHEET 1 AA9 4 MET B 4 THR B 5 0 SHEET 2 AA9 4 VAL B 19 ALA B 25 -1 O LYS B 24 N THR B 5 SHEET 3 AA9 4 ASP B 70 ILE B 75 -1 O ILE B 75 N VAL B 19 SHEET 4 AA9 4 PHE B 62 SER B 67 -1 N SER B 65 O THR B 72 SHEET 1 AB1 5 PHE B 10 SER B 12 0 SHEET 2 AB1 5 THR B 102 GLU B 105 1 O LYS B 103 N MET B 11 SHEET 3 AB1 5 GLU B 85 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AB1 5 VAL B 33 GLN B 38 -1 N GLN B 38 O GLU B 85 SHEET 5 AB1 5 LYS B 45 TYR B 49 -1 O LYS B 45 N GLN B 37 SHEET 1 AB2 4 GLN A 3 GLN A 5 0 SHEET 2 AB2 4 LYS A 19 SER A 25 -1 O LYS A 23 N GLN A 5 SHEET 3 AB2 4 THR A 78 LEU A 83 -1 O ALA A 79 N CYS A 22 SHEET 4 AB2 4 ALA A 68 THR A 71 -1 N THR A 71 O TYR A 80 SHEET 1 AB3 6 ALA A 9 VAL A 12 0 SHEET 2 AB3 6 THR A 114 VAL A 118 1 O THR A 117 N GLU A 10 SHEET 3 AB3 6 ALA A 92 ARG A 98 -1 N TYR A 94 O THR A 114 SHEET 4 AB3 6 MET A 34 THR A 40 -1 N GLN A 39 O VAL A 93 SHEET 5 AB3 6 GLY A 44 ILE A 51 -1 O GLY A 49 N TRP A 36 SHEET 6 AB3 6 THR A 58 TYR A 60 -1 O SER A 59 N ALA A 50 SHEET 1 AB4 4 ALA A 9 VAL A 12 0 SHEET 2 AB4 4 THR A 114 VAL A 118 1 O THR A 117 N GLU A 10 SHEET 3 AB4 4 ALA A 92 ARG A 98 -1 N TYR A 94 O THR A 114 SHEET 4 AB4 4 TYR A 109 TRP A 110 -1 O TYR A 109 N ARG A 98 SSBOND 1 CYS G 336 CYS G 361 1555 1555 2.03 SSBOND 2 CYS G 379 CYS G 432 1555 1555 2.03 SSBOND 3 CYS G 391 CYS G 525 1555 1555 2.06 SSBOND 4 CYS G 480 CYS G 488 1555 1555 2.03 SSBOND 5 CYS L 23 CYS L 87 1555 1555 2.03 SSBOND 6 CYS H 22 CYS H 96 1555 1555 2.03 SSBOND 7 CYS B 23 CYS B 88 1555 1555 2.03 SSBOND 8 CYS A 22 CYS A 96 1555 1555 2.03 LINK ND2 ASN G 343 C1 NAG G 601 1555 1555 1.43 CISPEP 1 SER L 7 PRO L 8 0 -2.57 CISPEP 2 TYR B 94 PRO B 95 0 2.24 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000